New York, USA – December 17, 2020 – The vaccine is absolutely a hotspot of new drug discovery, which has gained considerable share on the market. For years, many vaccines approved by the FDA have helped humans against various diseases, even fatal ones. At present, vaccines are undisputed the hope to defeat the COVID-19 that is rampaging throughout the world. Creative Biolabs supports the pre-clinical research of vaccine development, covering a variety of vaccine types, such as live attenuated and killed vaccines, subunit vaccines, hapten conjugate vaccines, and DNA and RNA vaccines. Not only requisite raw materials but also technical solutions are offered to global clients to accelerate their R&D projects.
High standard vaccine antigen products are available in large inventory, including viral antigens, parasitic antigens, bacterial antigens, and tumor antigens, which have satisfactory sensitivity and specificity and can be used as immunogens and serological based diagnostic tests as well.
• Viral Antigens: Adenovirus, Aquareovirus, Astrovirus, Bluetongue Virus, etc.
• Bacterial Antigens: Aeromonas, Arthrobacter Globiformis, Bacillus, Bordetella, etc.
• Fungal Antigens: Aspergillus, Candida Albicans, Pichia Pastoris, Saccharomyces, etc.
• Tumor Antigens: 2B4, 4-1BB, 4-1BBL, Activin A, etc.
In addition to the antigens, Creative Biolabs also supplies serum-free and ultra-low protein medium, delivery systems, antibodies of high sensitivity and specificity, array kits, and various adjuvants for vaccine development.
At Creative Biolabs, high-end techniques are adopted for vaccine design solutions. Multiple antigen display technologies embedded Outer Membrane Vesicles (OMVs) platform is exclusive and the core to a successful design of a valid vaccine. For the in silico vaccine design service, robust database and in silico models are established and adopted for lead candidate selection and rational design. Vaccine target discovery and verification can assist with screening out successful antigen candidates. Taking advantage of the next generation sequencing technology, DNA and RNA sequence information is obtained in a more efficient manner.
“Our products for vaccine development are in large stock,” said a scientist at Creative Biolabs. The vaccine products are readily available for quick delivery. Because of the current crisis of COVID-19, the entire health system is challenged, and Creative Biolabs aims to accelerate any relevant vaccine project with high standard products, conscientious solutions, and the spirit of devotion.
More details can be found here: https://www.creative-biolabs.com/vaccine.
Creative Biolabs is a specialized service provider to assist with vaccine pre-clinical development projects from worldwide clients. For over a decade, Creative Biolabs has successfully completed dozens of successful projects, and the products have reached the customers that belong to the pharmaceutical, institutional, and research areas throughout the world, receiving a good reputation and regular customers.